Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$378M |
| 2 |
TJX Companies
TJX
|
+$346M |
| 3 |
Pfizer
PFE
|
+$336M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$317M |
| 5 |
Linde
LIN
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$536M |
| 3 |
Applied Materials
AMAT
|
+$524M |
| 4 |
Warner Bros
WBD
|
+$319M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$299M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.09% |
| 2 | Financials | 11.94% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
3326
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $540K | ﹤0.01% |
23,409
-1,187,123
| -98% | -$33.1M |
|
|
FLY
3327
DELISTED
Fly Leasing Limited
FLY
| $540K | ﹤0.01% |
+32,037
| New | +$362K |
|
3328
NVE Corp
NVEC
$555M
| $538K | ﹤0.01% |
7,675
-2,650
| -26% | -$180K |
|
3329
RBB Bancorp
RBB
$446M
| $537K | ﹤0.01% |
26,485
-12,539
| -32% | -$238K |
|
3330
Cactus
WHD
$4.97B
| $537K | ﹤0.01% |
17,558
-5,258
| -23% | -$159K |
|
|
MEN
3331
DELISTED
Blackrock Muni Enhanced Fund, Inc.
MEN
| $534K | ﹤0.01% |
45,197
+4,890
| +12% | +$58.5K |
|
|
INFN
3332
DELISTED
Infinera Corporation Common Stock
INFN
| $532K | ﹤0.01% |
55,270
-127,578
| -70% | -$1.25M |
|
3333
Horizon Technology Finance
HRZN
$300M
| $530K | ﹤0.01% |
36,870
+1,837
| +5% | +$25.5K |
|
|
NEWR
3334
DELISTED
New Relic, Inc.
NEWR
| $530K | ﹤0.01% |
8,621
-35,861
| -81% | -$2.38M |
|
|
MOFG
3335
DELISTED
MidWestOne Financial Group
MOFG
| $529K | ﹤0.01% |
17,104
-5,343
| -24% | -$152K |
|
3336
Weis Markets
WMK
$1.92B
| $529K | ﹤0.01% |
9,365
-80
| -0.8% | -$4.29K |
|
|
GRA
3337
DELISTED
W.R. Grace & Co.
GRA
| $528K | ﹤0.01% |
8,820
+342
| +4% | +$20.4K |
|
|
JRO
3338
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $527K | ﹤0.01% |
48,440
-2,239
| -4% | -$20.7K |
|
3339
Aegon
AEG
$14B
| $526K | ﹤0.01% |
120,462
-11,474
| -9% | -$48K |
|
3340
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.5B
| $525K | ﹤0.01% |
13,471
+592
| +5% | +$24.6K |
|
3341
Arbutus Biopharma
ABUS
$871M
| $523K | ﹤0.01% |
157,028
-480,264
| -75% | -$1.85M |
|
|
PFC
3342
DELISTED
Premier Financial Corp. Common Stock
PFC
| $523K | ﹤0.01% |
15,735
-7,400
| -32% | -$219K |
|
3343
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
| $520K | ﹤0.01% |
8,804
-2,467
| -22% | -$140K |
|
3344
First Trust S&P REIT Index Fund
FRI
$190M
| $520K | ﹤0.01% |
20,647
+1,505
| +8% | +$36.3K |
|
3345
JPMorgan BetaBuilders Japan ETF
BBJP
$17.7B
| $519K | ﹤0.01% |
9,112
-2,701
| -23% | -$155K |
|
|
TCS
3346
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $517K | ﹤0.01% |
+2,073
| New | +$463K |
|
3347
Huazhu Hotels Group
HTHT
$13B
| $515K | ﹤0.01% |
9,386
+830
| +10% | +$44.4K |
|
|
TTM
3348
DELISTED
Tata Motors Limited
TTM
| $515K | ﹤0.01% |
24,747
-1,196
| -5% | -$24.1K |
|
3349
Horizon Bancorp
HBNC
$1.05B
| $514K | ﹤0.01% |
27,639
-6,084
| -18% | -$108K |
|
3350
BioCryst Pharmaceuticals
BCRX
$2.35B
| $512K | ﹤0.01% |
50,334
-20,240
| -29% | -$209K |
|
Similar funds
Ameriprise's Q1 2021 Portfolio in Review
As of Q1 2021, Ameriprise held 3,961 positions worth $301B, up 6.7% from $282B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q1 2021 filing shows 208 new, 1,854 increased, 1,673 reduced and 132 closed positions. Its largest new stake was ON24: 907,983 shares worth $44M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2021 buy was ON24: 907,983 shares worth $44M.
- Ameriprise added most to RTX Corp in Q1 2021, an estimated $378M increase.
- Ameriprise's biggest Q1 2021 reduction was Apple, cutting an estimated $1.19B.
- Ameriprise fully exited WPX Energy, Inc. in Q1 2021, selling an estimated $75.9M.
- Ameriprise's ten largest holdings make up 15% of its $301B portfolio in Q1 2021.
- Ameriprise opened 208 new positions and closed 132 in Q1 2021.
- Ameriprise's portfolio value rose 6.7% quarter-over-quarter to $301B.
Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.